Hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer

BACKGROUND: To investigate the clinical outcomes and toxicity of hypofractionated radiotherapy for medically inoperable stage I non‐small cell lung cancer (NSCLC). METHODS: Patients treated with radiotherapy at a dose of 4–6 Gy per fraction using fixed‐field intensity modulated radiotherapy (IMRT) o...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Wei, Wang, Jian‐Yang, Wang, Jing‐Bo, Liang, Jun, Hui, Zhou‐Guang, Wang, Xiao‐Zhen, Zhou, Zong‐Mei, Wang, Lu‐Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2015
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846617/
https://www.ncbi.nlm.nih.gov/pubmed/27148414
http://dx.doi.org/10.1111/1759-7714.12327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4846617/
https://www.ncbi.nlm.nih.gov/pubmed/27148414
http://dx.doi.org/10.1111/1759-7714.12327

Ejemplares similares